Understanding mechanism of disease and identifying therapeutic interventions with HUB Organoids™ 

Fill in the form to watch our presentation

watch on demand hub organoids for diease modelling and drug development

Talk highlights

Classic in vitro disease models are based on 2D immortalized cell lines that poorly recapitulate the morphology, physiology and genetic background of the original patient disease. In this presentation Dr Rob Vries, CEO at HUB will discuss:

  • How HUB Organoids™ bridge the gap between the lab and clinic, offering more clinically relevant in vitro models that faithfully mimic human disease pathology and physiology
  • That HUB Organoids can effectively predict patient response when used in drug screen, thus improving the current drug discovery and development process